FDA
-
-
-
-
-
-
-
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
-
-
-
-
-
-
-
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
-
-
-
-
-
-
-
DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
-
-
-
-
-
-
-
DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico
-
-
-
-
-
-
-
DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE.
-
-
-
-
-
-
-
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
-
-
-
-
-
-
-
IRIS, a New Look Vision Group Inc. company, teams up with DIAGNOS in a multi-year agreement to implement Artificial Intelligence technology with support from the INVEST-AI Program
-
322,217 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

